XPH 股價展望與 ETF 分析 - 配息·管理費·持股·NAV·RSI·MACD | 美股今日
詳細指標表
| Category | US Equities - Industry Sector | Expense | 0.35% | Return% 1Y | 33.98% | Total Holdings | 64 | Perf Week | 3.35% | Volume | 230,676 |
| Asset Type | Equities (Stocks) | AUM | $454M | Return% 3Y | 22.45% | NAV | $65.25 | Perf Month | 1.6% | Avg Volume | 0.16M |
| ETF Type | US Equities | Dividend TTM | $0.28 (0.42%) | Return% 5Y | 7.53% | 52W High | -12.84% | Perf Quarter | -5.03% | Rel Volume | 1.4 |
| Active/Passive | Passive | Div Gr. 3/5Y | -11.55% 13.67% | Return% 10Y | 5.44% | 52W Low | 36.13% | Perf Half Y | 10.79% | Prev Close | $65.18 |
| IPO | 2006/6/22 | Flows% 1M | -13.31% | Return% SI | 9.03% | RSI (14) | 51.45 | Perf YTD | 15.69% | Price | $64.80 |
| Beta | 0.63 | Flows% 3M | -1.39% | Flows% YTD | 67.48% | Flows% 1Y | 80.85% | Perf Year | 31.41% | Volatility(W/M) | 1.75% 2.04% |
| SMA20 | 2.09% | SMA50 | -2.72% | SMA200 | 4.95% | ATR | 1.33 | ||||
SPDR S&P Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").
前 10 大持股占 基金的 29%
均勻分散在眾多持股中。
依持股比重由大到小。
過去一年中, 屬於中等
較一年最高價低 13%。
成交量高於平時。 相當於平均成交量的140%。
若長期持有 表現出色
若 5 年前買入,現在的報酬率為 +35.1%。 同期標普 500 為 +65%。
點擊查看數字
價格 波動較大
最糟時(2015年12月)下跌了 38%,花了 267 天才恢復。
點擊查看數字
股息 配息偏少
每年可領取 0.42% 的股息。
點擊查看數字
資金持續流入
最近一年流入了相當於資產 80.8% 的新資金。
點擊查看數字
常見問題
XPH 投資了多少檔標的?
XPH 總共持有 64 檔標的,AUM 約為 $454M。
XPH 有配息嗎?
XPH 的配息殖利率約為 0.42%。
XPH 的 52 週最高價與最低價是多少?
XPH 在過去 52 週最高為 $74.35,最低為 $47.60。